obstructive sleep apnea
Conditions
Interventions
control group :observation for 3 months
drug group :drug therapy for 3 months
Sponsors
Department of Otolaryngology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Eligibility
Sex/Gender
All
Age
3 Years to 6 Years
Inclusion criteria
Inclusion criteria: 1. Preschool children aged 3-6 years old; 2. According to the results of portable sleep monitor RDI, according to the American Academy of Sleep Medicine guidelines. Mild OSA was 1 time/h = 10 times/h. Children with RDI < 10 times/h were included; 3. The patient was returned to the hospital after three months of drug treatment. Sleep monitoring indicators, visual analog scale scores, children's quality of life and children's anxiety scale scores were improved before and after treatment, and the clinical data were complete.
Exclusion criteria
Exclusion criteria: 1. Mechanical obstruction caused by other causes, such as abnormal airway anatomy and maxillofacial development; 2. Central sleep apnea syndrome: including neuromuscular disease, Down syndrome, laryngeal malacia, etc.; 3. After adenoid or tonsil surgery; 4. History of allergy to Monreuster sodium and glucocorticoid.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| portable monitor parameter; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Score;Disease-specific quality of life for children with obstructive sleep apnea 18;Spence Preschoolers Anxiety Scale; | — |
Countries
China
Contacts
Public ContactPeiyao Wang
Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Outcome results
None listed